Amphastar Pharmaceuticals Inc vs Celestica Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Celestica Inc trades at $315 (market cap $39.16B). The key difference: Celestica Inc is far larger — about 45.1× Amphastar Pharmaceuticals Inc's market cap, and Celestica Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | CLS | |
|---|---|---|
Market Cap | $868.62M | $39.16B |
Sector | Health | Technology |
52-Week High | $30.81 | $472.40 |
52-Week Low | $16.87 | $181.34 |
Enterprise Value | $1.27B | $39.44B |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Celestica provides supply chain and manufacturing solutions for global technology companies. It specializes in high-complexity assembly and platform solutions for AI data centers, aerospace, and medical markets.
Read more on CLS →